September 2026 Trial Snapshot
💻
Best viewed on desktop
The Lupus trial snapshot includes an interactive map and data tables that work best on a larger screen.
Read the Lupus research guide →Active sponsors
Trials
A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases
Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus Erythematosus
Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic Patients
Serum MPO-DNA Complexes as a Biomarker of Disease Activity in Systemic Lupus Erythematosus
Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers
FT839 in Autoimmune Diseases
Study to Evaluate the Safety and Preliminary Efficacy of CD19 CAR-T Cell Therapy (TranspoCART19) in Patients With Refractory Lupus Nephritis
Team-based Implementation of Hypertension Management in Childhood Lupus
Dissecting Immunological and Autoimmune Mechanisms of Neuropsychiatric Diseases
Predictors of ICU Admission and In-Hospital Mortality in Hospitalized Patients With Lupus Nephritis: The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and C Reactive Protein to Serum Albumin Ratio
Showing trials with activity in the past 30 days. See the full Lupus research landscape →
Condition guide
Lupus — the full picture
Research landscape, trial types, and what eligibility typically looks like — written for patients but useful for everyone.
Monthly digest
Get this brief every month
We’ll email you the Lupusbrief as soon as it’s published — no login required.
Coming soon